Agendia News

Genetic test helps doctors treat breast cancer patients

A genetic test that can give patients peace of mind and cut down on over treatment.

Learn More >>

The Latest Advances in the Fight Against Breast Cancer

Dr. Kristi Funk discusses the MammaPrint molecular diagnostic test.

New Game Changer in Breast Cancer Fight?

GMA: Dr. Funk looks at latest advancements, ways to help prevent breast cancer

TV Story on MammaPrint Inventor

Laura van ‘t Veer, Ph.D is recognized by Netherlands TV show “Patent uit de Polder” for winning the European Inventor Award for creating the MammaPrint, 70-gene breast cancer recurrence test.

Charleston physician leads country in testing for breast cancer ‘sub-type’

(The Post and Courier, 2014)
When Summer Flynn felt a large lump in her breast earlier this year, she insists she wasn’t worried.

TreatmentSOS: Genomics & Breast Cancer.

( (
Dr. James Pellicane, Dir. of Breast Oncology at Bon Secours Cancer Institute. What is genomic testing?
Learn More >>

HER2 Guideline Won’t Deter Genomic Testing.

In recent years we have seen substantial research into the role of the HER2 gene and development of HER2-targeted therapies to treat breast cancer.
(Oncology Times, 2013)

New Insight Into Discordant Breast Tumor Subtyping.

Traditional estrogen receptor (ER) testing with immunohistochemistry (IHC) assays—and more recently with mRNA—provides clinicians with a key roadmap for breast cancer subtyping and treatment planning.
(Chemotherapy Advisor, 2013)

More research urged to compare and validate genomic tests in oncology

“Almost one out of three patients could change their adjuvant therapy due to genomic testing.”
(ESMO, 2013)

The Promise of Molecular Breast Tumor Subtyping.

Will molecular-genomic panels like MammaPrint overcome the limitations of histo- and clinicopathological breast cancer subtyping, to better personalize patients’ treatment strategies and prognoses?
Read more>>
(Chemotherapy Advisor, 2013)

Are you in denial about your risk for getting breast cancer? Many women are as this article points out.

A study’s author says women’s skepticism about risks leads some to put off preventive medicine, while others may undergo unnecessary treatments.

(, 2013)

Major changes urged for cancer screening and treatment: Scientific panel recommends new personalized strategies to reduce cancer overtreatment

Scientific panel recommends new personalized strategies to reduce cancer overtreatment.
(UCSF, 2013)

Scientists Seek to Rein In Diagnoses of Cancer

The panel said that some premalignant conditions found in mammograms should not be identified as “carcinoma.”
(New York Times, 2013)

Using Genomic Testing to Steer Clinical Treatment Decisions

Improved understanding of how to integrate the results into the treatment planning process is changing the course of treatment for some patients.
(Oncology Nurse Advisor, 2013)

New Test Eliminates Chemo Need for Some Breast Cancer Patients

A new gene test for patients with breast cancer – MammaPrint – could dramatically reduce the number of women who need chemotherapy.
(Lincoln Journal Star, 2013)

Study Divides Breast Cancer Into Four Distinct Types

In findings that are fundamentally reshaping the scientific understanding of breast cancer, researchers have identified four genetically distinct types of the cancer.
(New York Times, 2012)

New breast cancer clues found in gene analysis

Scientists reported Sunday that they have completed a major analysis of the genetics of breast cancer, finding four major classes of the disease.
(Associated Press, 2012)

Study eyes the genetics of breast cancer

NBC’s Chief Health and Science Correspondent Robert Bazell talks about how a study of DNA in breast tumors opens up the possibility of trying new drugs to battle the disease.
(NBC Nightly News, 2012)

Advances in breast cancer genetics study

In a move that could alter the way that breast cancers are treated, researchers have redefined the disease into four main classes and determined that one type of breast cancer has more in common with an aggressive form of ovarian cancer than other breast cancers.
(San Francisco Chronicle, 2012)

Genome project links breast and ovarian cancers

Scientists announced Sunday that they have finished mapping virtually all of the genetic mutations in breast cancer, an effort that could soon change the way patients are treated and eventually help researchers develop better treatments.
(USA Today, 2012)

Gene Study Yields New Clues to Breast Cancer

A comprehensive look at the genetic blueprint of breast cancer has revealed new insights into the disease — including the discovery that certain breast and ovarian tumors may be closely related.
Read more
(HealthDay, 2012)

Around The Web

    Feed has no items.